These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25288922)

  • 21. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.
    Halder RC; Aguilera C; Maricic I; Kumar V
    J Clin Invest; 2007 Aug; 117(8):2302-12. PubMed ID: 17641782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.
    Maricic I; Sheng H; Marrero I; Seki E; Kisseleva T; Chaturvedi S; Molle N; Mathews SA; Gao B; Kumar V
    Hepatology; 2015 Apr; 61(4):1357-69. PubMed ID: 25477000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycolipids as immune modulatory tools.
    Lalazar G; Preston S; Zigmond E; Ben Yáacov A; Ilan Y
    Mini Rev Med Chem; 2006 Nov; 6(11):1249-53. PubMed ID: 17100636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice.
    Liu Y; Teige A; Mondoc E; Ibrahim S; Holmdahl R; Issazadeh-Navikas S
    J Clin Invest; 2011 Jan; 121(1):249-64. PubMed ID: 21157037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor.
    Patel O; Pellicci DG; Gras S; Sandoval-Romero ML; Uldrich AP; Mallevaey T; Clarke AJ; Le Nours J; Theodossis A; Cardell SL; Gapin L; Godfrey DI; Rossjohn J
    Nat Immunol; 2012 Sep; 13(9):857-63. PubMed ID: 22820603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
    Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
    J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of NKT cells in tumor immunity.
    Terabe M; Berzofsky JA
    Adv Cancer Res; 2008; 101():277-348. PubMed ID: 19055947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of CD1d-restricted antigens by natural killer T cells.
    Rossjohn J; Pellicci DG; Patel O; Gapin L; Godfrey DI
    Nat Rev Immunol; 2012 Dec; 12(12):845-57. PubMed ID: 23154222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.
    Sebode M; Wigger J; Filpe P; Fischer L; Weidemann S; Krech T; Weiler-Normann C; Peiseler M; Hartl J; Tolosa E; Herkel J; Schramm C; Lohse AW; Arrenberg P
    Front Immunol; 2019; 10():1065. PubMed ID: 31191516
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.
    Shin JH; Park SH
    BMB Rep; 2014 May; 47(5):241-8. PubMed ID: 24755556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type II NKT Cells and Their Emerging Role in Health and Disease.
    Dhodapkar MV; Kumar V
    J Immunol; 2017 Feb; 198(3):1015-1021. PubMed ID: 28115591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
    J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
    Zajonc DM; Kronenberg M
    Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
    Amanuma R; Nakajima T; Yoshie H; Yamazaki K
    J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-Specific Roles of NKT Cells in Tumor Immunity.
    Terabe M; Berzofsky JA
    Front Immunol; 2018; 9():1838. PubMed ID: 30158927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NKT Cells Contribute to the Control of Microbial Infections.
    Vogt S; Mattner J
    Front Cell Infect Microbiol; 2021; 11():718350. PubMed ID: 34595131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.
    Liu W; Huber SA
    Virol J; 2011 Jan; 8():32. PubMed ID: 21255407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.